3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
27
Neoplasm Metastasis
4
Advanced Breast Cancer
4
Neoplasms
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
HR+/HER2- Breast Cancer
2
Endometrial Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sexual Dysfunctions, Psychological
1
Recurrence
1
Polycystic Ovary Syndrome
1
Pathologic Complete Response
1
Neoplasms by Site
1
Low Grade Serous Ovarian Carcinoma
1
Leiomyoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hemangiosarcoma
1
Head and Neck Neoplasms
1
HER2 Negative Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasm Female
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Interventions
pembrolizumab
1
Pemetrexed
1
Cisplatin
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Processes
×
Letrozole
×
30 days
×
Clear all
No trials found.